11A
PFE icon

10-15 Associates’s Pfizer PFE Stock Holding History

10-15 Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$13.9M Sell
397,784
-7,706
-2% -$270K 2.69% 13
2020
Q2 		$12.6M Buy
405,490
+4,623
+1% +$157K 2.54% 18
2020
Q1 		$12.4M Buy
400,867
+32,444
+9% +$1.11M 2.89% 10
2019
Q4 		$13.7M Buy
368,423
+4,966
+1% +$177K 2.59% 10
2019
Q3 		$12.4M Buy
363,457
+3,991
+1% +$145K 2.55% 15
2019
Q2 		$14.8M Sell
359,466
-6,854
-2% -$272K 3.21% 5
2019
Q1 		$14.8M Buy
366,320
+4,549
+1% +$182K 3.17% 6
2018
Q4 		$15M Sell
361,771
-19,222
-5% -$798K 3.67% 4
2018
Q3 		$15.9M Buy
380,993
+4,340
+1% +$167K 3.57% 2
2018
Q2 		$13M Buy
376,653
+9,753
+3% +$333K 2.91% 8
2018
Q1 		$12.4M Buy
366,900
+19,064
+5% +$655K 2.94% 7
2017
Q4 		$12M Buy
347,836
+537
+0.2% +$18.3K 2.86% 12
2017
Q3 		$11.8M Buy
347,299
+14,788
+4% +$475K 2.97% 7
2017
Q2 		$10.6M Buy
332,511
+7,779
+2% +$245K 2.98% 9
2017
Q1 		$10.5M Buy
324,732
+17,721
+6% +$559K 2.89% 10
2016
Q4 		$9.46M Buy
307,011
+20,998
+7% +$641K 2.65% 13
2016
Q3 		$9.19M Buy
286,013
+79,633
+39% +$2.66M 2.56% 12
2016
Q2 		$6.89M Buy
206,380
+8,015
+4% +$256K 1.98% 19
2016
Q1 		$5.58M Buy
198,365
+2,977
+2% +$85K 1.74% 25
2015
Q4 		$5.98M Buy
195,388
+17,086
+10% +$538K 1.74% 24
2015
Q3 		$5.31M Buy
178,302
+158,957
+822% +$5.1M 1.82% 25
2015
Q2 		$615K Buy
19,345
+532
+3% +$17.3K 0.19% 76
2015
Q1 		$620K Buy
18,813
+113
+0.6% +$3.59K 0.21% 81
2014
Q4 		$552K Buy
18,700
+5,226
+39% +$150K 0.18% 81
2014
Q3 		$378K Buy
13,474
+1,679
+14% +$47.1K 0.13% 91
2014
Q2 		$332K Buy
11,795
+3,908
+50% +$111K 0.11% 91
2014
Q1 		$240K Buy
+7,887
New +$235K 0.08% 97

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

10-15 Associates's PFE Position: Q3 2020 in Review

10-15 Associates reduced its Pfizer (PFE) stake by 1.9% in Q3 2020, selling an estimated $270K and leaving 397,784 shares worth $13.9M. The position accounts for 2.69% of the portfolio, ranked #13.

10-15 Associates first reported a position in PFE in Q1 2014 and has held it in 27 quarters since. The position peaked at $15.9M in Q3 2018. 2,509 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

  • 10-15 Associates held 397,784 shares of Pfizer worth $13.9M as of Q3 2020.
  • 10-15 Associates sold 7,706 Pfizer shares in Q3 2020, an estimated $270K.
  • Pfizer made up 2.69% of 10-15 Associates's portfolio in Q3 2020, its #13 holding.
  • 10-15 Associates first reported a position in Pfizer in Q1 2014 and has held it in 27 quarters since.
  • 10-15 Associates's Pfizer position peaked at $15.9M in Q3 2018.
  • 2,509 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on 10-15 Associates's 13F filing for Q3 2020, filed 13 Oct 2020.